An overview of the MOP runtime verification framework von Meredith, Patrick O’Neil, Jin, Dongyun, Griffith, Dennis, Chen, Feng, Roşu, Grigore

Volltext

Efficient monitoring of parametric context-free patterns von Meredith, Patrick O’Neil, Jin, Dongyun, Chen, Feng, Roşu, Grigore

Volltext

JavaMOP: Efficient parametric runtime monitoring framework von Dongyun Jin, Meredith, Patrick O'Neil, Choonghwan Lee, Rosu, Grigore

Volltext

Maximal sound predictive race detection with control flow abstraction von Huang, Jeff, Meredith, Patrick O'Neil, Rosu, Grigore

Volltext

Efficient Formalism-Independent Monitoring of Parametric Properties von Feng Chen, O'Neil Meredith, P., Dongyun Jin, Rosu, G.

Volltext

RV-Monitor: Efficient Parametric Runtime Verification with Simultaneous Properties von Luo, Qingzhou, Zhang, Yi, Lee, Choonghwan, Jin, Dongyun, Meredith, Patrick O’Neil, Şerbănuţă, Traian Florin, Roşu, Grigore

Volltext

Garbage collection for monitoring parametric properties von Jin, Dongyun, Meredith, Patrick O'Neil, Griffith, Dennis, Rosu, Grigore

Volltext

Garbage collection for monitoring parametric properties von Jin, Dongyun, Meredith, Patrick O'Neil, Griffith, Dennis, Rosu, Grigore

Volltext

Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study von O'Neil, Patrick M., Smith, Steven R., Weissman, Neil J., Fidler, Meredith C., Sanchez, Matilde, Zhang, Jinkun, Raether, Brian, Anderson, Christen M., Shanahan, William R.

Volltext

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial von Fidler, Meredith C, Sanchez, Matilde, Raether, Brian, Weissman, Neil J, Smith, Steven R, Shanahan, William R, Anderson, Christen M

Volltext

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity von Kelly, Aaron S, Auerbach, Pernille, Barrientos-Perez, Margarita, Gies, Inge, Hale, Paula M, Marcus, Claude, Mastrandrea, Lucy D, Prabhu, Nandana, Arslanian, Silva

Volltext

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled... von Camenzind, Edoardo, Dr, Wijns, William, MD, Mauri, Laura, MD, Kurowski, Volkhard, MD, Parikh, Keyur, MD, Gao, Runlin, Prof, Bode, Christoph, Prof, Greenwood, John P, MD, Boersma, Eric, Prof, Vranckx, Pascal, MD, McFadden, Eugene, MD, Serruys, Patrick W, Prof, O'Neil, William W, MD, Jorissen, Brenda, PhD, Van Leeuwen, Frank, MD, Steg, Ph Gabriel, Prof

Volltext

Factors leading to supranormal cardiac index in pediatric pulmonary hypertension patients treated with parenteral prostanoid therapy von Miles, Kimberley G, Critser, Paul J, Evers, Patrick D, Cash, Michelle, Magness, Melissa, Geers, Elizabeth, O'Neil, Meredith, Gao, Zhiqian, Ollberding, Nicholas J, Hirsch, Russel

Volltext

The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial von Burns, Daniel K., Chiang, Carl, Welsh-Bohmer, Kathleen A., Brannan, Stephen K., Culp, Meredith, O'Neil, Janet, Runyan, Grant, Harrigan, Patrick, Plassman, Brenda L., Lutz, Michael, Lai, Eric, Haneline, Stephen, Yarnall, David, Yarbrough, Deborah, Metz, Craig, Ponduru, Sridevi, Sundseth, Scott, Saunders, Ann M., Dubois, Bruno, Cummings, Jeffrey, Doody, Rachelle, Lyketsos, Constantine, Reiman, Eric, Welsh-Bohmer, Kathleen A., Welsh-Bohmer, Kathleen A., Sano, Mary, Schneider, Lon, Craft, Suzanne, Espeland, Mark, Monsch, Andreas

Volltext

ADJUDICATING MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER’S DISEASE AS A NOVEL ENDPOINT EVENT IN THE TOMMORROW STUDY: A DELAY-OF-ONSET PHASE 3 CLINICAL TRIAL von Chiang, Carl, Alexander, Robert, Welsh-Bohmer, Kathleen A., Plassman, Brenda L., Romero, Heather, Hayden, Kathleen M., Keefe, Richard SE, Atkins, Alexandra S., Harrigan, Patrick, O'Neil, Janet, Culp, Meredith, Walter, Ryan, Wu, Jingtao, Randle, LaDonna, Haneline, Stephen, Yarbrough, Deborah, Metz, Craig, Burns, Daniel K., Saunders, Ann M.

Volltext

P1‐050: ADJUDICATING MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE AS A NOVEL ENDPOINT EVENT IN THE TOMMORROW STUDY: A DELAY‐OF‐ONSET PHASE 3 CLINICAL TRIAL von Chiang, Carl, Alexander, Robert, Welsh-Bohmer, Kathleen A., Plassman, Brenda L., Romero, Heather, Hayden, Kathleen M., Keefe, Richard SE, Atkins, Alexandra S., Harrigan, Patrick, O'Neil, Janet, Culp, Meredith, Walter, Ryan, Wu, Jingtao, Randle, LaDonna, Haneline, Stephen, Yarbrough, Deborah, Metz, Craig, Burns, Daniel K., Saunders, Ann M.

Volltext

P4‐383: Characterization of the Screened Population for the Tommorrow Study: a Pharmacogenetics‐Supported Clinical Trial to Delay the Onset of Mild Cognitive Impairment Due to Alzh... von Martenyi, Ferenc, Welsh-Bohmer, Kathleen A., Plassman, Brenda L., Harrigan, Patrick, Chiang, Carl, O'Neil, Janet, Runyan, Grant, Culp, Meredith, Lutz, Michael W., Lai, Eric, Saunders, Ann M., Haneline, Stephen, Yarnall, David, Yarbrough, Deborah, Metz, Craig, Burns, Daniel K., Roses, Allen D.

Volltext

APPROACHES TO SUBJECT RETENTION IN A PHASE 3 DELAY-OF-ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER’S DISEASE (MCI-AD) CLINICAL TRIAL: THE TOMMORROW STUDY EXPERIENCE von Welsh-Bohmer, Kathleen A., Plassman, Brenda L., Chiang, Carl, Culp, Meredith, Harrigan, Patrick, O'Neil, Janet, Walter, Ryan, Haneline, Stephen, Arbuckle, Julian, Brewster, Shyama, Maruyama, Yuka, Swanson, Tom, Fitzsimmons, Dominic, Atkins, Alexandra S., Keefe, Richard S.E., Burns, Daniel K., Martenyi, Ferenc

Volltext

CHARACTERIZATION OF THE SCREENED POPULATION FOR THE TOMMORROW STUDY: A PHARMACOGENETICS-SUPPORTED CLINICAL TRIAL TO DELAY THE ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER’S... von Martenyi, Ferenc, Welsh-Bohmer, Kathleen A, Plassman, Brenda L, Harrigan, Patrick, Chiang, Carl, O'Neil, Janet, Runyan, Grant, Culp, Meredith, Lutz, Michael W, Lai, Eric, Saunders, Ann M, Haneline, Stephen, Yarnall, David, Yarbrough, Deborah, Metz, Craig, Burns, Daniel K, Roses, Allen D

Volltext